Sr. Director - Aesthetic Health External Innovation

Role: Executive Director, Aesthetic Health External Innovation — responsible for identifying and evaluating external programs and assets in aesthetic medicine, including biologics, small molecules, devices, and delivery platforms. Main objectives include sourcing innovative opportunities, executing partnerships, and integrating external science into Lilly's strategic portfolio. Responsibilities involve leading deal closures, building external relationships with biotech, academia, and industry partners, and conducting landscape analyses to identify emerging technologies. The role requires active engagement in deal negotiations, coordinating cross-functional internal teams, and supporting indication planning and prioritization efforts. Qualifications: Ph.D. in Dermatology, Cell Biology, or related fields; M.D. with specialty in Dermatology or Plastic Surgery; 10+ years of industry experience with a proven track record in external innovation, licensing, and business development within dermatology or aesthetic medicine; deep mechanistic knowledge of skin biology and therapeutic modalities. Preferred skills include experience with startup creation, venture capital, global collaboration, and leadership in high-stakes negotiations. High-value specifics: focus on cutaneous biology, skin aging, hair biology, and adjacent aesthetic indications; involvement in early to late-stage development; familiarity with novel modalities like cell therapy and gene medicine; domestic and international travel up to 40%. Collaboration primarily with strategic partners, academic institutions, and internal discovery and commercial teams. Work setup involves frequent travel with a focus on external partnership development.